In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
India is scheduled to conduct a ballistic missile test from Wheeler Island (Odisha's Abdul Kalam
In many states including Delhi, UP, and Uttarakhand, it has been raining heavily for the last few
Prime Minister Narendra Modi on Monday lauded the Union Budget presented in Parliament on Februar
Anti-Corona Vaccine The vaccine of Pfizer/BioNTech will be only 47 percent effective after six mo
The shooters arrested for the murder of Punjabi singer Sidhu Moosewala have made a new revelation
The two-day first All India State Ministers Annual Conference on the theme 'Water Vision 2047' ha
Referring to Goddess Durga, Rajnath Singh praised Indira Gandhi, said – had led even in war
Defense Minister Rajnath Singh has praised former Prime Minister Indira Gandhi fiercely. Speaking
Is Iran moving towards accepting the Taliban?
On Sunday, a high-level delegation of the Taliban reached the Iranian capital Tehran to discuss e
Corona Updates: 1,716 new cases found in 24 hours, 3 patients died; 400 active patients reduced
In the last 24 hours, 1,716 new cases of corona have been reported in the country and 3 patients
The ever-increasing cases of digital arrest are a matter of concern for the people. Due to this n
